Guidelines for Hepatitis C Virus Antibody Testing and Reporting

Clinical guidelines for laboratory testing and result reporting of antibody to hepatitis C virus (anti-HCV). The document expands recommendations to include an option for reflex supplemental testing based on screening-test signal-to-cut-off ratios. It was developed by CDC staff in consultation with the FDA and representatives from public health, hospital, and independent laboratories.

Use Cases

• Develop standardized laboratory testing protocols based on the described reflex supplemental testing guidelines.
• Train machine learning models to interpret anti-HCV test results based on signal-to-cut-off ratios mentioned in the description.
• Analyze variation in laboratory testing practices based on the described guidelines for result reporting.

Strengths

• Guidelines developed by CDC staff in consultation with the FDA and multiple laboratory representatives.
• Includes specific recommendations for using signal-to-cut-off ratios to improve result reliability.

Limitations

• The dataset is a single text document; no structured data or column-level information is provided.
• Row count and file format are unknown, limiting suitability assessment for computational tasks.
• License is listed as closed, which may restrict usage.

Provenance

Source

Centers for Disease Control and Prevention (CDC)

Collection Method

Developed by CDC staff in consultation with external representatives.